2 results about "Liquid glucose" patented technology

The invention discloses a device for improving continuous separation of glucose and fructose by a simulated moving bed, and relates to the technical field of organic compound separation. The problem that in the prior art, glucose and fructose are separated is solved. The device specifically comprises an upstream storage tank module, an upstream rotary joint module, a separation module, a downstream rotary joint module, a downstream storage tank module and an inert gas supply module, and the upstream storage tank module, the upstream rotary joint module, the separation module, the downstream rotary joint module, the downstream storage tank module and the inert gas supply module are operated in parallel. According to the present invention, the resin mounted in the column is kept in a semi-dry state to eliminate the displacement zone of the traditional chromatography operation process, while reducing the consumption of the resin, the feed solution is separated into pure liquid glucose and pure liquid fructose at a yield of 100%, while reducing the consumption of water for washing and dewatering, thereby reducing the production cost. Therefore, the dry solid% concentration of the product and the by-product is improved.

The present invention relates to a polyherbal tablet formulation for the treatment of gouty arthritis and hyperuricemia. The formulation comprises ethanol extracts of six medicinal plants, each contributing specific bioactive compounds with xanthine oxidase (XO) inhibitory, antioxidant, and anti-inflammatory properties. The tablet includes Colchicum autumnale (50mg), Berberis vulgaris (100 mg), Apium graveolens (25 mg), Capparis decidua (25 mg), Fagonia cretica (25 mg), and Trachyspermum ammi (75 mg), combined with a liquid glucose solution to form a 300 mg tablet. The manufacturing method involves ethanol extraction of each plant (70% ethanol, 72 hours), filtration, solvent evaporation under reduced pressure, blending of equal amounts of the extracts with glucose, and drying at 50°C for 12 hours. The resulting formulation demonstrates enhanced therapeutic efficacy in reducing uric acid levels and alleviating joint inflammation, supported by in vitro and in vivo pharmacological assays.